AMITRIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Amitril, and when can generic versions of Amitril launch?
Amitril is a drug marketed by Warner Chilcott and is included in six NDAs.
The generic ingredient in AMITRIL is amitriptyline hydrochloride. There are thirteen drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the amitriptyline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Amitril
A generic version of AMITRIL was approved as amitriptyline hydrochloride by SUN PHARM INDS INC on July 14th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMITRIL?
- What are the global sales for AMITRIL?
- What is Average Wholesale Price for AMITRIL?
Summary for AMITRIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 124 |
Patent Applications: | 2,828 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AMITRIL at DailyMed |
![AMITRIL drug patent expirations Drug patent expirations by year for AMITRIL](/p/graph/s/t/AMITRIL-patent-expirations.png)
US Patents and Regulatory Information for AMITRIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Warner Chilcott | AMITRIL | amitriptyline hydrochloride | TABLET;ORAL | 083939-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Warner Chilcott | AMITRIL | amitriptyline hydrochloride | TABLET;ORAL | 084957-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Warner Chilcott | AMITRIL | amitriptyline hydrochloride | TABLET;ORAL | 083937-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |